Mito Red Cross Hospital
In research, Mito Red Cross Hospital stands highest in Health Sciences (#19,884 of 20,462 worldwide), over all time.
- World rank, all time
- #41,688 of 42,892
- Rank in Japan
- #2,041 of 2,112
- Research works
- 138 ▼ 36% vs 2013–17
- Citations
- 1.5k 10.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 60% world 28%
What is Mito Red Cross Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #19,884 of 20,462 | 4.8% | 121 |
Each strip is that field’s whole ranked pool, with the notch where Mito Red Cross Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Mito Red Cross Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Clinical Practice Guidelines, Treatment, Diagnosis, Risk Factors, Deep Vein Thrombosis, Hypertension and Quality of Life.
- Immunohistochemistry
- Immunosuppressive Therapy
- Therapeutic Targets
- Inferior Vena Cava
- Molecular Profiling
- Imatinib Mesylate
- Fibrosis
- Rituximab
- Genetic Mutations
- PET Imaging
- Immunotherapy
- Chronic Venous Insufficiency
- Pulmonary Embolism
- Prognostic Factors
- Metabolic Syndrome
- Chemotherapy
- Inflammation
- Quality of Life
- Diagnosis
- Clinical Practice Guidelines
- Epidemiology
- Treatment
- Risk Factors
- Deep Vein Thrombosis
- Hypertension
- Cardiovascular Disease
- Antithrombotic Therapy
- Surgical Management
- Venous Thromboembolism
- Varicose Veins
- Autoantibodies
- Cardiovascular Events
- Survival Analysis
- Radiotherapy
- Mitochondrial Dysfunction
- Molecular Characterization
- Clinical Guidelines
- Superior Mesenteric Artery Syndrome
- Aldosterone
- Primary Aldosteronism
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology20▲ 3.6×41 topics
- Clinical Practice Guidelines14▲ 18×9 topics
- Treatment14▲ 7.7×21 topics
- Diagnosis12▲ 8.8×16 topics
- Risk Factors10▲ 7.0×11 topics
- Quality of Life8▲ 4.5×12 topics
- Deep Vein Thrombosis8▲ 67×2 topics
- Inflammation8▲ 2.4×25 topics
- Hypertension7▲ 13×8 topics
- Chemotherapy6▲ 6.6×12 topics
- Cardiovascular Disease6▲ 3.6×14 topics
- Metabolic Syndrome6▲ 4.7×11 topics
- Antithrombotic Therapy6▲ 38×2 topics
- Prognostic Factors6▲ 8.7×10 topics
- Surgical Management6▲ 8.8×9 topics
- Pulmonary Embolism5▲ 56×1 topic
- Venous Thromboembolism5▲ 56×1 topic
- Chronic Venous Insufficiency5▲ 161×1 topic
- Varicose Veins5▲ 161×1 topic
- Immunotherapy5▲ 5.1×11 topics
- Autoantibodies4▲ 14×6 topics
- PET Imaging4▲ 15×4 topics
- Cardiovascular Events4▲ 18×2 topics
- Genetic Mutations4▲ 5.4×9 topics
- Survival Analysis4▲ 10×5 topics
- Rituximab4▲ 17×4 topics
- Radiotherapy4▲ 6.9×7 topics
- Fibrosis3▲ 12×3 topics
- Mitochondrial Dysfunction3▲ 6.6×7 topics
- Imatinib Mesylate3▲ 40×2 topics
- Molecular Characterization3▲ 12×4 topics
- Molecular Profiling3▲ 19×3 topics
- Clinical Guidelines3▲ 7.0×6 topics
- Inferior Vena Cava3▲ 106×1 topic
- Superior Mesenteric Artery Syndrome3▲ 106×1 topic
- Therapeutic Targets3▲ 8.8×3 topics
- Aldosterone3▲ 44×1 topic
- Immunosuppressive Therapy3▲ 11×4 topics
- Primary Aldosteronism3▲ 44×1 topic
- Immunohistochemistry3▲ 20×3 topics
Which research topics does Mito Red Cross Hospital publish most on?
By volume in 2022–2025: Diagnosis and Treatment of Venous Diseases, Venous Thromboembolism Diagnosis and Management, Central Venous Catheters and Hemodialysis and Vascular anomalies and interventions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diagnosis and Treatment of Venous Diseases Surgery 1 works
- 2 Venous Thromboembolism Diagnosis and Management Internal Medicine 1 works
- 3 Central Venous Catheters and Hemodialysis Emergency Medical Services 1 works
- 4 Vascular anomalies and interventions Surgery 1 works
- 5 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 6 Vascular Procedures and Complications Pulmonary and Respiratory Medicine 0 works
- 7 Dermatologic Treatments and Research Dermatology 0 works
- 8 Hernia repair and management Surgery 0 works
- 9 Peripheral Artery Disease Management Surgery 0 works
- 10 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Mito Red Cross Hospital's research output changed?
Output in 2018–2022 was 36% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ibaraki
- Ibaraki University
- RIKEN BioResource Research Center
- Mito Saiseikai General Hospital
- Tsukuba International University
- Tokyo Medical University Ibaraki Medical Center
- Institute for Animal Reproduction
- Otemon Gakuin University
- Kasumigaura Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.